A pilot open-label trial of minocycline in patients with autism and regressive features

BACKGROUND: Minocycline is a tetracycline derivative that readily crosses the blood brain barrier and appears to have beneficial effects on neuroinflammation, microglial activation and neuroprotection in a variety of neurological disorders. Both microglial activation and neuroinflammation have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardo, Carlos A, Buckley, Ashura, Thurm, Audrey, Lee, Li-Ching, Azhagiri, Arun, Neville, David M, Swedo, Susan E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663771/
https://www.ncbi.nlm.nih.gov/pubmed/23566357
http://dx.doi.org/10.1186/1866-1955-5-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663771/
https://www.ncbi.nlm.nih.gov/pubmed/23566357
http://dx.doi.org/10.1186/1866-1955-5-9

Ejemplares similares